The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
- Andreas Höhn*
- , Anita Jeyam
- , Thomas M. Caparrotta
- , Stuart J. McGurnaghan
- , Joseph E. O’Reilly
- , Luke A. K. Blackbourn
- , Rory J. McCrimmon
- , Graham P. Leese
- , John A. McKnight
- , Brian Kennon
- , Robert S. Lindsay
- , Naveed Sattar
- , Sarah H. Wild
- , Paul M. McKeigue
- , Helen M. Colhoun
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review